Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates
- 31 January 1995
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 13 (1), 22-28
- https://doi.org/10.1016/0264-410x(95)80006-y
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Killed Campylobacter elicits immune response and protection when administered with an oral adjuvantVaccine, 1993
- Safety and Immunogenicity of the Oral, Whole Cell/Recombinant B Subunit Cholera Vaccine in North American VolunteersThe Journal of Infectious Diseases, 1993
- The adjuvant effect of Vibrio cholerae and Escherichia coli heat‐labile enterotoxins is linked to their ADP‐ribosyltransferase activityEuropean Journal of Immunology, 1992
- Safety and Immunogenicity of Different Immunization Regimens of CVD 103-HgR Live Oral Cholera Vaccine in Soldiers and Civilians in ThailandThe Journal of Infectious Diseases, 1992
- ISCOMS — a novel strategy for mucosal immunization?Immunology Today, 1991
- Active immunity is seen as a reduction in the cell response to oral live vaccineVaccine, 1991
- Cross-Protection by B Subunit-Whole Cell Cholera Vaccine Against Diarrhea Associated with Heat-Labile Toxin-Producing Enterotoxigenic Escherichia coli: Results of a Large-Scale Field TrialThe Journal of Infectious Diseases, 1988
- Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigensVaccine, 1988
- Experimental Campylobacter jejuni Infection in HumansThe Journal of Infectious Diseases, 1988
- Mucosal Antitoxic and Antibacterial Immunity after Cholera Disease and after Immunization with a Combined B Subunit-Whole Cell VaccineThe Journal of Infectious Diseases, 1984